Updated August 16, 2026Expert Reviewed

Best Semaglutide Providers at 2.4mg in 2026 Ranked & Reviewed

One filter builds this table: the seller publishes a semaglutide price at 2.4mg. Sellers who stock other tiers and skip this one drop out, which is why the list runs shorter than the full semaglutide board. Each row carries the max dose figure a seller advertises, the date we last checked it, and our independent score. Whether 2.4mg is the right tier for you is a call for your prescriber.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

1 semaglutide providers compared · independently scored against our six-factor methodology.

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Methodology & sources

Each provider here carries a score from our published six-factor rubric[1], and the list is then cut down to the dose named in the page title.

Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[2]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[3].

Quick Picks: Top 1

#ProviderScore
1Coby HealthVisit

Detailed Reviews

1

Coby Health

Best for: compounded semaglutide at $159/month

6.7

Coby Health LLC runs a direct-to-consumer telehealth marketplace out of Chicago and Springfield, IL, with a BBB file opened 3/2025. Compounded semaglutide starts at $99/mo and compounded tirzepatide at $179/mo, both on a 6-mo bundle at the 0.25mg and 2.5mg starting doses. There is no membership fee. It is LegitScript Certified (seal 38387067), and clinical care runs through Beluga Health P.A., part of the Dr. Jonah Mink network. It does not publicly disclose its compounding pharmacy partners.

Score Breakdown

Value25%
6.2
Effectiveness25%
10
User Experience15%
3
Trust & Safety15%
4
Accessibility10%
9.4
Support10%
7

Frequently Asked Questions

Sources & methodology — as of August 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)GLP Watchdog.
  2. 2.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  3. 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.